Evidence map›Paper›PMID 35356246›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Molecular Analysis of Xmn1-Polymorphic Site ´5 to G

Abozer Y Elderdery, Abdullah Alsrhani, Badr Alzahrani, Muhammad Atif, Ahmed I Refaiy, Hussain Shiwani, Amin Abbas, Dawelbiet A Yahia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abozer Y ElderderyDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID https://orcid.org/0000-0002-6219-5312
Abdullah AlsrhaniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID https://orcid.org/0000-0002-6839-8866
Badr AlzahraniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID https://orcid.org/0000-0003-4158-640X
Muhammad AtifDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID https://orcid.org/0000-0002-8921-4376
Ahmed I RefaiyLaboratories and Blood Banks Administration, Jazan, Saudi Arabia.ORCID https://orcid.org/0000-0003-1582-9703
Hussain ShiwaniKing Fahad Central Hospital, Jazan, Saudi Arabia.ORCID https://orcid.org/0000-0002-7561-3907
Amin AbbasAlreqqa Medical Center, Madinah, Saudi Arabia.ORCID https://orcid.org/0000-0003-1635-0542
Dawelbiet A YahiaDepartment of Biochemistry, Faculty of Medicine, University of El Imam El Mahdi, Kosti, Sudan.ORCID https://orcid.org/0000-0003-0528-3612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The southern part of Saudi Arabia has an ethnically diverse population where sickle-cell anemia (sickle cell disease) is common, but little is known about its

Identifiers

PMID35356246
PMCPMC8959949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.